Application of Megavoltage Imaging to Reduce Artifact After Seed Implants



Status:Completed
Conditions:Prostate Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:50 - 80
Updated:9/28/2017
Start Date:September 2013
End Date:April 2016

Use our guide to learn which trials are right for you!

Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma

This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure
in patients treated with interstitial permanent seed implants for low and intermediate risk
prostate cancer. All patients will received the same standard of care treatment but will
receive an additinoal CT image of the prostate.


Inclusion Criteria:

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion Criteria:
We found this trial at
1
site
Lexington, Kentucky 40536
?
mi
from
Lexington, KY
Click here to add this to my saved trials